However, Hiroaki et al. indicated that ICAM-1 could reduce lymph node metastasis, which left the specific effect of ICAM-1 in peritoneal metastasis unknown [34]. Here, ICAM1 is linked to metastatic malignant neoplasm in the lymph nodes.